GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Gross Margin of 38.53% for Q1 2026, down 2.9% on a QoQ basis from 39.68% in Q4 2025, and down 359.0% year-over-year from 14.88% in Q1 2025.
GE HealthCare Technologies (GEHC) Gross Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Gross Margin history runs 5 years deep, the most recent figure standing at 38.53% for Q1 2026.
- Quarterly Gross Margin fell 359.0% year-over-year to 38.53% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 39.15% (down 285.0% YoY) and the FY2025 annual result came in at 39.99%, down 172.0% from the prior year.
- Gross Margin was 38.53% for Q1 2026 at GE HealthCare Technologies, down from 39.68% in the prior quarter.
- Across five years, Gross Margin topped out at 42.77% in Q4 2024 and bottomed at 38.53% in Q1 2026.
- A 5-year average of 40.23% and a median of 40.13% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin jumped 229 bps — and 2026, when it tumbled 359 bps.
- GE HealthCare Technologies' Gross Margin stood at 39.13% in 2022, then gained by 6 bps to 41.41% in 2023, then grew by 3 bps to 42.77% in 2024, then retreated by 7 bps to 39.68% in 2025, then retreated by 3 bps to 38.53% in 2026.
- Business Quant data shows GEHC's Gross Margin at 38.53% in Q1 2026, 39.68% in Q4 2025, and 38.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 43.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.53% |
| Dec 31, 2025 | 39.68% |
| Sep 30, 2025 | 38.69% |
| Jun 30, 2025 | 39.64% |
| Mar 31, 2025 | 42.12% |
| Dec 31, 2024 | 42.77% |
| Sep 30, 2024 | 41.66% |
| Jun 30, 2024 | 41.37% |
| Mar 31, 2024 | 40.90% |
| Dec 31, 2023 | 41.41% |
| Sep 30, 2023 | 40.13% |
| Jun 30, 2023 | 40.27% |
| Mar 31, 2023 | 40.17% |
| Dec 31, 2022 | 39.13% |
| Sep 30, 2022 | 38.75% |
| Jun 30, 2022 | 40.05% |
| Mar 31, 2022 | 38.64% |